Sorafenib Accord ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

SORAFENIB S.K. 200mg Film tableta মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

sorafenib s.k. 200mg film tableta

"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - sorafenib - film tableta - 200mg